Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data.

Giovanni Marchegiani,Stefano Andrianello,Chiara Dal Borgo,Erica Secchettin,Davide Melisi,Giuseppe Malleo,Claudio Bassi,Roberto Salvia

HPB（2019）

引用 35|浏览7

暂无评分

摘要

Adjuvant therapy improves survival only in invasive IPMNs with nodal disease or tubular differentiation. Future trials are needed to improve the level of evidence about adjuvant chemotherapy.

查看译文

关键词

adjuvant chemotherapy,pancreas,postoperative survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要